Johnson & Johnson (NYSE:JNJ) 8th Annual SVB Leerink Global Healthcare Conference February 28, 2019 11:00 AM ET
Company Participants
Chris DelOrefice – Vice President of Investor Relations
Ashley McEvoy – Executive Vice President, Worldwide Chairman, Medical Devices
Conference Call Participants
Danielle Antalffy – SVB Leerink LLC
Danielle Antalffy
Good morning. Oh, can you hear me? Okay. Perfect. Good morning, everyone. Welcome to the SVB Leerink Healthcare Conference. My name is Danielle Antalffy. I am one of the medtech analysts here at SVB Leerink. And we are very lucky to have with us from Johnson & Johnson, Ashley McEvoy. So let me make sure I get your title correct, EVP and Worldwide Chairman of Medical Devices.
And also from Investor Relations, we have Chris DelOrefice and also Matthew Stuckley. He will start us off with some of the disclosures.
Chris DelOrefice
Thanks, Danielle. Good morning, everyone. Please be aware that some statements made today may be considered forward-looking or utilize non-GAAP measures. Please refer to our SEC filings, in particular, 10-K, which discuss the risks and uncertainties around forward-looking statements as well as our website at investor.jnj.com for reconciliations to comparable GAAP measures.
Finally, any performance measures made today represent results through and including the fourth quarter of 2018. Thank you. Danielle?
